echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Progress of drug bidding in 2014 and analysis of key provincial bids

    Progress of drug bidding in 2014 and analysis of key provincial bids

    • Last Update: 2014-07-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: worry free bidding 2014-7-9 I progress of projects in the first half of the year in all provinces and cities provincial project name bidding progress remarks: centralized procurement of drugs (basic drugs + non basic drugs) in medical institutions of Jilin Province in 2013 June 24, 2013 The bidding has been launched in the announcement of the people's Republic of China on July, and now the result of winning the bid has been announced The distribution enterprises have announced three batches The bidding for basic drugs of Shanghai in 2013 has been completed The price confirmation and negotiation of the first batch of bidding for medical insurance of Shanghai in 2013 have been completed, waiting for implementation In 2014, the review and confirmation of centralized purchasing data of basic drugs in Anhui Province has been completed Recently, 1118 varieties of basic drugs in Shandong Province have been publicized with the review results and quotation In 2013, the centralized purchasing of drugs by public medical institutions in Hunan Province (basic drugs + non-basic drugs) has been basically completed The results of data review have been published, waiting for the announcement of price limit and quotation Guangdong basic drug exchange in 2013 is now in 201406 rounds of announcement and the volume is approaching maturity In 2012, non basic drug bids in Hainan Province have been opened, and the distribution marathon type of basic drug bids in Gansu Province in 2014 was not checked Fill in the basic drug bids online information in Ningxia 2014 Ningxia basic drugs in 2012 (the 2012 edition of national basic drugs has basically ended, and the notice on the implementation of the second batch of bid winning results has been issued The application materials of Chengdu war zone bid review enterprises in 2014 in Chengdu Military Region have not been reviewed yet 2 The project name of provinces and cities that have published the opinion draft, Fujian Province, Fujian Province, 2014 implementation opinion on centralized drug procurement of medical institutions in Fujian Province Implementation plan for centralized drug purchase of medical institutions at or above the county level in Jiangxi Province in 2014 work plan for centralized drug purchase in Hubei Province in 2014 (for comments) draft for centralized drug purchase plan in 2014 in Shaanxi Province in Shaanxi Province (3), key analysis of three provincial standards (1) and Guangdong basic drug standard (1) The Guangdong based drug standard has been stumbling to the 201406 round, though it has been repeatedly Tucao, and has caused a sharp increase in in-house work and make complaints about industrial and commercial medicine, but is still firmly advancing However, according to the bidding plans issued by the provinces, Guangdong Pharmaceutical exchange mode has not been recognized and followed by the industry (2) In the past, there were so many exclusive varieties of bidding projects in Guangdong base drugs The total number of exclusive product specifications was the total number of product specifications The proportion of exclusive product specifications in the first round was 1851, 943, 50.9%, 201405, 1825, 946, 51.8%, 201406, 1859, 943, 50.7% More than half of the basic drug regulations belong to exclusive basic drugs, which can only exclaim the spirit of the leader in the supplement of basic drugs in Guangdong (3) According to the statistical data, compared with the second round, the average price reduction rate of enterprises with the same product specification in the first round is 0.58%, and 79.58% of the bidding price remains unchanged Compared with the third round, the average price reduction rate in the second round is 0.54%, among which 81.03% of the bidding price remains unchanged Compared with the third round, the average price reduction rate in the first round is 0.76% The price of most enterprises winning the bid twice has not changed It can be seen that the only way to get low prices is to take them, resulting in the phenomenon of "where there is oppression, there is resistance" The result is rather strange and worth pondering 2 Make complaints about the basic drugs in Anhui (1) the way to check the data again in Anhui I believe that there are a lot of enterprises that have submitted more than three times On June 27, I received another message from Anhui pharmaceutical purchasing center, asking us to confirm the bidding information before 17:00 on June 29 During this period, a lot of enterprises have already confirmed it and are still called back to ask for resubmission I hope all my friends have confirmed it in time on Sunday afternoon Is there any subsidy for weekend overtime??? (2) Policy signals of the basic drug Catalog: A There are 1118 varieties, covering all national basic drug varieties Non basic drug varieties in other catalogs will also be protected Varieties not in this catalog will only be amazed B It coincides with the national policy of setting up the catalogue of centralized drug purchase in public hospitals, which has super foresight and has been imitated by Fujian Province The front of medical reform is worthy of the name C It can be predicted that the market share of non-medical insurance varieties will be less and less in the future (3) Recently, we will publicize the review information and quotation of materials The progress is relatively fast According to the rumor, it was planned to offer in June, but now it seems that we can only wait until July The price limit will not be publicized before the quotation Please pay attention to the calculation of the price limit by yourself, so as to avoid missing the opportunity when the quotation is higher than the price limit From the perspective of price limit rules, the principle of Hunan refining is followed, but the standards of refining are different: the number of drugs in the commercial bid evaluation group is ≤ 2, the lowest price in eight provinces is taken; the number of drugs in the commercial bid evaluation group is ≥ 3, the average price in seven provinces and the low price in 2012 county level are taken as the price limit, and the price limit ratio for exclusive varieties is relatively strict (4) Today, Anhui publicizes the review results of materials, which contain too much information to obtain: a the sales volume of competitive products in 2013, which is the first exposure; B the quality type of competitive products, from which we can know the grouping situation; C It is determined that the sterile drugs entrusted for production cannot be registered; D calculate the scores of technical bids in a timely manner, and it is expected that a quotation will be made in the near future 3 Characteristics of bidding (1) for Shanghai basic drugs and medical insurance (the first batch): as mentioned in the previous article, the bidding process is the process of price negotiation It is the only province that can win the bid without bidding for non basic drugs, the only province that does not lose the bid for products, and the only province that does not have quality evaluation Price limit has become the most critical constraint for this project (2) This kind of bidding mode is relatively loose, and all manufacturers of the same product specification win the bid, which introduces a complete market competition mechanism However, because there is no secondary price negotiation process, the cost control of medical insurance will become a problem, fortunately, Shanghai has money (3) Not representative In the first half of 2014, the policy gradually became clear, and the bidding policy for low-cost drugs and the drug bidding management measures have taken shape For example, Jilin provincial standard and Hainan non base drug standard have been opened, Hunan provincial standard data review has been completed; Anhui basic drug standard data review has been completed; Ningxia Shaanxi and other northwest regions base drug standard has been steadily promoted In the second half of 2014, Fujian, Jiangxi, Sichuan, Hubei and other provinces were ready to move After a wave of ups and downs, the bidding people should keep up their spirits and let the storm come more violently!
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.